Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Oral Drug Delivery Systems: Introduction01:23

Oral Drug Delivery Systems: Introduction

Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
Drug Delivery Systems: Different Types01:27

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interactions of the flavonols quercetin, fisetin, kaempferol, and myricetin with liposomal membranes.

Acta chimica Slovenica·2026
Same author

Cyclodextrin-Based Nanocarriers for 5-Fluorouracil: Cholesteryl Modification Enhances Antitumor Activity Against Colorectal Cancer Cells.

International journal of nanomedicine·2026
Same author

Medicinal Mushrooms and Their Bioactive Compounds: From Traditional Use to Therapeutic Potential.

Molecules (Basel, Switzerland)·2026
Same author

Lithocholic Acid-Derived Imidazolium Salts Suppress Breast Cancer Growth: In Vitro and In Vivo Evaluation.

Pharmaceutical research·2026
Same author

Targeted delivery of doxorubicin via cholesteryl-modified cyclodextrin: Antitumor activity in breast, ovarian, and cervical cancer cell lines.

Chemico-biological interactions·2026
Same author

Therapeutic potential of bile acids and synthetic strategies of their incorporation into polymeric drug delivery systems.

Journal of materials chemistry. B·2026

Related Experiment Video

Updated: May 16, 2026

Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

Nanoparticles as drug delivery systems.

Agnieszka Z Wilczewska1, Katarzyna Niemirowicz, Karolina H Markiewicz

  • 1Institute of Chemistry, University of Bialystok, al. J. Pilsudskiego 11/4, PL 15-433 Białystok, Poland.

Pharmacological Reports : PR
|December 15, 2012
PubMed
Summary
This summary is machine-generated.

Controlled drug delivery systems (DDS) enhance therapy by targeting drug delivery, minimizing side effects. Magnetic nanoparticles show promise as advanced DDS carriers, offering targeted accumulation and reduced dosages.

More Related Videos

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
09:47

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

Related Experiment Videos

Last Updated: May 16, 2026

Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
09:47

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Pharmacology

Background:

  • Traditional drug administration often leads to systemic side effects and suboptimal therapeutic concentrations.
  • Controlled drug delivery systems (DDS) aim to improve drug efficacy and safety by precise delivery.
  • Nanocarriers offer novel solutions for targeted drug delivery and controlled release.

Purpose of the Study:

  • To review various nanocarriers used in drug delivery systems.
  • To analyze the functionalization of magnetic nanoparticles (MNPs) as drug carriers.
  • To discuss the advantages and disadvantages of using MNPs in DDS.

Main Methods:

  • Literature review of nanocarriers in drug delivery.
  • Analysis of nanostructure-drug conjugation strategies.
  • Focus on functionalization techniques for magnetic nanoparticles.

Main Results:

  • Various nanostructures like liposomes, polymers, dendrimers, and magnetic nanoparticles are effective DDS carriers.
  • Functionalized magnetic nanoparticles offer enhanced targeting capabilities for drug delivery.
  • MNPs demonstrate potential for increased drug accumulation at target sites, enabling lower doses.

Conclusions:

  • Magnetic nanoparticles represent a promising class of nanocarriers for advanced drug delivery systems.
  • Functionalization of MNPs is key to optimizing their performance in targeted therapy.
  • Further research into MNP-based DDS can lead to improved therapeutic outcomes and reduced toxicity.